Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression

Matthew B. Wall, Lysia Demetriou, Bruna Giribaldi, Leor Roseman, Natalie Ertl, David Erritzoe, David J. Nutt, Robin L. Carhart-Harris
doi: https://doi.org/10.1101/2023.05.29.23290667

Article Information

doi 
https://doi.org/10.1101/2023.05.29.23290667
History 
  • June 3, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Matthew B. Wall1,2,3,
  2. Lysia Demetriou1,2,4,
  3. Bruna Giribaldi5,
  4. Leor Roseman5,
  5. Natalie Ertl1,2,
  6. David Erritzoe5,
  7. David J. Nutt5 and
  8. Robin L. Carhart-Harris5,6
  1. 1Invicro London, Hammersmith Hospital, UK
  2. 2Faculty of Medicine, Imperial College London, UK
  3. 3Clinical Psychopharmacology Unit, University College London, UK
  4. 4Nuffield Department of Women’s and Reproductive Health, University of Oxford
  5. 5Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Faculty of Medicine, Imperial College London
  6. 6Psychedelics Division, Neuroscape, University of California San Francisco, USA
  1. Corresponding Author: Matthew B. Wall matt.wall{at}invicro.co.uk
Back to top
Posted June 03, 2023.
Download PDF
Data/Code
Email
Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression
Matthew B. Wall, Lysia Demetriou, Bruna Giribaldi, Leor Roseman, Natalie Ertl, David Erritzoe, David J. Nutt, Robin L. Carhart-Harris
medRxiv 2023.05.29.23290667; doi: https://doi.org/10.1101/2023.05.29.23290667
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area